Literature DB >> 1456739

Three- and four-year cognitive outcome in children with noncortical brain tumors treated with whole-brain radiotherapy.

J Radcliffe1, R J Packer, T E Atkins, G R Bunin, L Schut, J W Goldwein, L N Sutton.   

Abstract

Cognitive function and school achievement were studied prospectively over 3 to 4 years in 19 children treated for brain tumors with whole-brain radiotherapy; 14 of 19 also received adjuvant chemotherapy. For the group as a whole, mean IQ fell from a baseline of 104 to 92 at follow-up (p < 0.01). Age was inversely correlated with change in IQ over time (r = 0.71; p < 0.001). Children younger than 7 years at diagnosis had a mean IQ loss of 27 points, while children over 7 years at diagnosis showed no significant decrease in IQ. Decline in IQ occurred between baseline and year 2 of follow-up; none could be documented between years 2 and 4. All children younger than 7 years at diagnosis were receiving special education at follow-up; 50% of the children over 7 years at diagnosis were receiving supplemental educational services.

Entities:  

Mesh:

Year:  1992        PMID: 1456739     DOI: 10.1002/ana.410320411

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  30 in total

1.  Radiation-induced neurocognitive decline: the risks and benefits of reducing the amount of whole-brain irradiation.

Authors:  Roger J Packer
Journal:  Curr Neurol Neurosci Rep       Date:  2002-03       Impact factor: 5.081

Review 2.  Neurological complications following treatment of children with brain tumors.

Authors:  Michelle Monje; Paul Graham Fisher
Journal:  J Pediatr Rehabil Med       Date:  2011

3.  Functional genomics identifies drivers of medulloblastoma dissemination.

Authors:  Michael Mumert; Adrian Dubuc; Xiaochong Wu; Paul A Northcott; Steven S Chin; Carolyn A Pedone; Michael D Taylor; Daniel W Fults
Journal:  Cancer Res       Date:  2012-08-08       Impact factor: 12.701

4.  Quality of life and behavioral follow-up study of Head Start I pediatric brain tumor survivors.

Authors:  Stephen A Sands; Keith P Pasichow; Rebecca Weiss; James Garvin; Sharon Gardner; Ira J Dunkel; Jonathan L Finlay
Journal:  J Neurooncol       Date:  2010-06-06       Impact factor: 4.130

Review 5.  Diagnostic and therapeutic stratification of childhood brain tumors: implications for translational research.

Authors:  Ian F Pollack
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

Review 6.  Aggressive infantile embryonal tumors.

Authors:  Tobey J MacDonald
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

7.  Neuropsychological sequelae of the treatment of children with medulloblastoma.

Authors:  M Dennis; B J Spiegler; C R Hetherington; M L Greenberg
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

Review 8.  Chemotherapy for medulloblastomas and primitive neuroectodermal tumors.

Authors:  B H Cohen; R J Packer
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

9.  The history of ependymoma management.

Authors:  Kyu-Won Shim; Dong-Seok Kim; Joong-Uhn Choi
Journal:  Childs Nerv Syst       Date:  2009-05-21       Impact factor: 1.475

Review 10.  A critical review of the clinical effects of therapeutic irradiation damage to the brain: the roots of controversy.

Authors:  Carol L Armstrong; Kunsang Gyato; Abdel W Awadalla; Robert Lustig; Zelig A Tochner
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.